MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Longitudinal Relationship Between Brain Metabolism and Clinical Changes in Huntington’s Disease

    A. Gravier, S. Lavisse, R. Massart, A. Gil-Salcedo, P. Lemercier, O. Barret, V. Gaura, AC. Bachoud-Levi, P. Remy (Créteil, France)

  • Longitudinal Structural and Functional Correlates of Progression in Isolated Rapid Eye Movement Sleep Behaviour Disorder

    L. Churchill, YC. Chen, J. Anderson, A. Ignatavicius, SJG. Lewis, E. Elie (Camperdown, Australia)

  • Longitudinal Studies of LFP Activities During Acute and Chronic DBS Stimulation in PD Patients

    Y. Zhao, V. Rayudu, S. Santacruz, M. Varga (Austin, USA)

  • Looking Away: Anxiety Interferes with the Ability of Freezers to Attend to Visual Cues

    P. Norouzian, A. Zafar, S. Lewis, K. Ehgoetz Martens (Waterloo, Canada)

  • Low intensity focused pulsed ultrasound as a treatment of essential tremor: a case series

    P. Medeiros Lacerda, G. Nunes, M. Torres, R. Iglesio, K. Massruha, M. Silva, V. Maciel, E. Barbosa, M. Teixeira, R. Nogueira, R. Cury (São Paulo, Brazil)

  • Lower Incidence of Parkinson’s Disease in Patients with Metabolic Syndrome or any of its Components: A Longitudinal Study

    R. Djaldetti, H. Avisar, U. Greenbaum, B. Lerner (Petah Tiqva, Israel)

  • Lower plasma piperine levels in Parkinson’s disease: a PPMI metabolomics analysis

    N. Xia, J. Ripping, R. Bakshi, E. Macklin, S. Molsberry, X. Chen, A. Ascherio, M. Schwarzschild (Charlestown, USA)

  • LRRK2 and GBA Founder Mutations and their Interactions in Parkinson’s Disease

    M. Kmiecik, G. Riboldi, R. Schneider, K. Stagaman, T. Filshtein Sonmez, A. Guan, M. Wetzel, P. Fontanillas, M. Holmes, S. Aslibekyan, L. Norcliffe-Kaufmann (Sunnyvale, USA)

  • LRRK2 G2019S mutant damages mitochondrial transfer by a Drp1-STX17 depend pathway in Parkinson’s disease

    X. Cheng (Suzhou, China)

  • LRRK2 Gene Mutation in Parkinson’s Disease

    A. Abbes, M. Mhiri, R. Ben Dhia, N. Gouta, M. Frih Ayed (Monastir, Tunisia)

  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley